Karlo Martin is a patient advocate and pioneer in bringing access to personalized medicines to global markets. As the senior real world evidence partner at PHAGE Corporation he works directly with pharmaceutical, medical device, and diagnostic manufacturers in supporting product development. Starting his career in the clinic, Karlo was a cytogeneticist diagnosing constitutional chromosomal abnormalities and neoplastic diseases. Getting a front row seat of pairing someone’s genetic profile and seeing how they responded to treatment drove Karlo into industry to learn more about personalized medicine.
His goal is to not only bring innovative treatments to the market but also focus on providing routes of access to desired health outcomes that are patient centric. Ultimately his goal is to champion marginalized patient populations and reduce the access barriers to care.